Allstate Corporation’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-15,684
Closed -$796K 705
2021
Q4
$796K Buy
15,684
+1,733
+12% +$77K 0.02% 581
2021
Q3
$565K Buy
13,951
+2,116
+18% +$107K 0.02% 483
2021
Q2
$670K Buy
11,835
+251
+2% +$14.3K 0.02% 440
2021
Q1
$613K Sell
11,584
-90
-0.8% -$4.9K 0.02% 480
2020
Q4
$638K Hold
11,674
0.02% 401
2020
Q3
$585K Buy
11,674
+204
+2% +$9.67K 0.02% 365
2020
Q2
$438K Hold
11,470
0.02% 476
2020
Q1
$251K Buy
11,470
+5,696
+99% +$171K 0.01% 535
2019
Q4
$237K Buy
+5,774
New +$236K ﹤0.01% 591

Other funds holding NUS

Allstate Corporation's NUS Position: Q1 2022 in Review

Allstate Corporation sold out of Nu Skin (NUS) in Q1 2022, closing a stake of 15,684 shares — an estimated $796K sold.

Allstate Corporation first reported a position in NUS in Q4 2019 and held it in 9 quarters. The position peaked at $796K in Q4 2021. 238 funds tracked by Wall St. Rank hold NUS as of Q1 2022.

  • Allstate Corporation reported no remaining Nu Skin position as of Q1 2022 after selling out during the quarter.
  • Allstate Corporation sold 15,684 Nu Skin shares in Q1 2022, an estimated $796K.
  • Allstate Corporation first reported a position in Nu Skin in Q4 2019 and held it in 9 quarters.
  • Allstate Corporation's Nu Skin position peaked at $796K in Q4 2021.
  • 238 funds tracked by Wall St. Rank held Nu Skin as of Q1 2022.

Based on Allstate Corporation's 13F filing for Q1 2022, filed 16 May 2022.